How Did a Stanford Surgeon and a Jiu-Jitsu Black Belt End Up Rewriting the Rules of Joint Health?

Not Your Average Surgeon

Dr. Scuderi is the kind of person you'd want in your corner, literally. He’s a world-class spine surgeon trained at Stanford... and a black belt in Brazilian Jiu-Jitsu. So yeah, he knows a thing or two about pain both as a doctor and as someone who’s likely taken a few knees to the ribs.

He’s been teaching and training since the '90s. He’s helped thousands of people walk again. But something kept bugging him: Why are we just managing joint pain when we could be solving it?

That simple question took him on a path that changed everything.


From the Operating Room to the Lab

You know how your body has all these built-in defense systems? Turns out one of those systems includes a little protein called alpha-2-macroglobulin (or A2M if you’re not in the mood for a tongue-twister).

A2M is like your cartilage’s personal bouncer. Its job? Block the enzymes (called proteases) that break down other proteins and cause tissue inflammation (including cartilage tissue).

The catch? Your body doesn’t send enough of it to the right place. So your joints get chewed up like they owe someone money.

Dr. Scuderi figured out how to pull that protein from your blood, super-concentrate it, and inject it right into the problem area. That therapy, called APIC™, achieved FDA clearance in 2015 and has since treated over 10,000 patients across the U.S.

But that was just step one.


Making a Good Thing Even Better

Scuderi being Scuderi, he didn’t stop there.

He thought: “Why are we relying on the body's limited supply of A2M when we can build a better version ourselves?”

So that’s what he did.

He and his team created CYT-108, a genetically engineered version of A2M that’s:

• Over 200% more effective at blocking those nasty cartilage-chewing enzymes
• Injected directly into the joints for maximum impact
• Designed to stop joint breakdown (before it leads to surgery) and trigger cartilage repair

This isn’t just another "joint support supplement" from the vitamin aisle. This is next-level, clinical study-backed therapy built to change the rules of how we treat joint pain.


Why Are We Talking About This Today?

Because on this Wednesday, in early-June, you might be wondering:

• Why are so many of us limping into our 50s?
• Why are joint replacements considered a normal part of aging?
• And why hasn’t anyone really fixed this yet?

That’s the same frustration Dr. Scuderi felt. So he did something about it. And now, you can be part of the solution too.


Wait, I Can Invest in This?

Yup.

Cytonics, the biotech company Dr. Scuderi founded; isn’t just looking for science journals and FDA approvals. They’re opening the door to everyday people, not just Wall Street.

• The company’s already raised $25M+ from regular folks
• Over 7,000+ investors have come onboard
• They’ve got 25+ patents protecting their science
• And now they’re preparing to publish their Phase 1 results (spoiler: they look very good!) and cruise into Phase 2 trials for CYT-108
• The science is moving forward at breakneck pace and the opportunity is still open while the company hits their pivotal R&D milestones

That means the science is moving and the opportunity is still open.


Final Thought

If you’re tired of quick fixes, recurring prescriptions, and being told that "joint pain is just part of getting older." Then maybe it’s time to bet on something better.

Because if a Stanford-trained surgeon and a jiu-jitsu black belt can shake up the system…

Maybe it’s time your investments did too.

Let’s make smarter medicine and smarter moves, together.

Your knees might thank you.

So might your portfolio.

Your move.